Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheuminations: The Power of the Placebo

Simon M. Helfgott, MD  |  Issue: October 2013  |  October 1, 2013

The Future Is Bright

Dr. Helfgott
Dr. Helfgott

A placebo works only if the patient believes it’s an effective medicine. Within strict limits, hope, it seems, can be transformed into biochemistry.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

—Carl Sagan, The Demon-Haunted World: Science as a Candle in the Dark

Could a greater miracle take place than for us to look through each other’s eyes for an instant?

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

—Henry David Thoreau

Making the diagnosis was the easy part. There were so many obvious clues. The limping gait when she entered the exam room, the flaccid handshake, the swollen knuckles. A textbook case of rheumatoid arthritis (RA). Mimi managed an organic farm in southern Vermont. At the outset of her visit, she conveyed her skepticism about the benefits of traditional medicine. She confided that she only kept her appointment with me to placate her older sister, a biomedical engineer.

Mimi’s knowledge of RA was quite impressive. She subscribed to several reliable medical websites and was aware of the treatment paradigms for her disease. We discussed the various options, yet she was hesitant about starting any drug regimen for managing her moderately severe RA. She believed that all drugs used to treat RA were toxic. Though I vehemently disagreed, I could not really blame her. The sheaf of information sheets outlining the potential side effects of the various disease-modifying drugs that I provided Mimi seemed to prove her point. Nausea, hair loss, risk for serious infection, liver inflammation, low blood counts—all were unacceptable risks for her. She was a woman who ran a successful organic farm and believed that there should be a better way for doctors to treat disease than by prescribing “toxins.” She was more interested in hearing about complementary therapies for RA. I explained that the term complementary meant using a non-mainstream approach together with, and not in place of, conventional medicine. Mimi thanked me for my time. She said that she would contact me with her decision, though it was obvious that I failed to convince her to begin any conventional therapy. I was deeply frustrated. Unlike many of the other diseases that we manage, RA is highly treatable, so it was disappointing to see her leave my office without a management plan.

A few months later, much to my surprise, Mimi paid a return visit. Outwardly, she looked the same as she did on her first visit—bright and cheerful—though her joints were still quite boggy and swollen. She told me that she found a “completely natural” herbal supplement online, which she was using to treat her RA. Not only was this supplement extremely effective in reducing joint pain and fatigue, it had no side effects! She felt “like a million bucks.” I was pleased to hear this news, but her persistent joint swelling concerned me. Mimi countered that with, “my hands are doing fine, and I can still do all my chores. So I see no reason to make any changes.” We parted ways. That was the last time I saw Mimi.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:OpinionPractice SupportRheuminationsSpeak Out Rheum Tagged with:patient careplaceborheumatology

Related Articles

    What Diet to Recommend to Patients with Rheumatoid Arthritis?

    November 1, 2013

    With no clear-cut, evidence-based dietary guidelines for RA, rheumatologists should advocate for a balanced diet to help patients reduce their risk of obesity, cardiovascular disease, and osteoporosis

    Diagnostic Tests, Tips for Gluten-Induced Celiac Disease

    June 13, 2016

    CHICAGO—Celiac disease—the gluten-induced illness that can be seen alongside rheumatic diseases—has been seen much more commonly over the past 20 years than it was previously, but the illness can come with questions that are not always straightforward, an expert said at the ACR’s State-of-the-Art Clinical Symposium. The disease, in which the small intestine becomes inflamed…

    Diet May Help Reduce Inflammation in RA

    March 27, 2023

    In a small study, an anti-inflammatory diet helped reduce pain and swelling in a subset of people with rheumatoid arthritis (RA). Diet changes are complementary to standard treatment. Diet-related research can be challenging, but many patients with RA are motivated to try healthy changes.

    The Role of T Cells in Celiac Disease

    April 17, 2017

    Celiac is an autoimmune disease with both gastrointestinal and neurological implications. A recent review examined the immunological research on celiac disease to date, detailing the role of T cells and the protein TG2 in disease pathology…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences